There has been a declining trend in morbidity rates in the last two days, almost two weeks after the restrictions began.
N12
| Posted 08/01/21 08:31
Decrease in morbidity data: The Ministry of Health updates this morning (Friday) that 7,597 new infections in Corona were diagnosed yesterday – when this is the third day in a row that there has been a certain decrease in data. The rate of positives was 6.2% and the number of critically ill patients is 873, with a declining trend in these data as well. 114,500 Israelis were vaccinated against Corona yesterday. This morning, the strict closure throughout Israel took effect.
For more updates and to send your stories – visit the news Facebook page
122,417 corona tests were performed yesterday. The number of active patients in Israel is 65,514. A figure that has still risen in recent days is the number of respiratory patients, which stood at 220 yesterday. From the beginning of the epidemic last March until today, 3,565 Israelis have died from Corona.
The beginning of the gradual decline recorded in recent days comes about two weeks after the beginning of the new restrictions. However, it seems that at this stage this is only a moderate decline. Tonight the stricter closure guidelines went into effect.
114,500 Israelis received their first vaccine against Corona yesterday. On Saturday night, Prime Minister Netanyahu and Health Minister Edelstein are expected to be the first Israelis to receive the second dose of vaccine.
The closure regulations that went into effect tonight include the closure of the education system as well as the tightening of restrictions on Israeli citizens. Prime Minister Netanyahu last night announced the advance of Pfizer vaccine shipments that will allow the acceleration of the vaccination campaign – and claimed that all citizens over the age of 16 will be vaccinated by the end of March. “The victory over the plague is within touching distance,” Netanyahu claimed. Meanwhile, Pfizer said this morning that preliminary findings suggest the vaccine is also effective against the new mutations found in the UK and South Africa.